Literature DB >> 19620499

Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice.

Myles J Lewis1, Talat H Malik, Michael R Ehrenstein, Joseph J Boyle, Marina Botto, Dorian O Haskard.   

Abstract

BACKGROUND: Immunoglobulin M (IgM) natural antibodies bind oxidatively-modified low-density lipoprotein (LDL) and apoptotic cells and have been implicated as being important for protection against atherosclerosis. We have directly investigated the requirement for IgM by studying the effects of IgM deficiency in LDL receptor-deficient (Ldlr(-/-)) mice. METHODS AND
RESULTS: Mice deficient in serum IgM (sIgM) or complement C1q were crossed with Ldlr(-/-) mice and studied on both low-fat and high-fat semisynthetic diets. On both diets, en face and aortic root atherosclerotic lesions in sIgM.Ldlr(-/-) mice were substantially larger and more complex, with accelerated cholesterol crystal formation and increased smooth muscle cell content in aortic root lesions. Combined C1q and IgM deficiency had the same effect as IgM deficiency alone. Increased apoptosis was observed in aortic root lesions of both sIgM.Ldlr(-/-) and C1qa.Ldlr(-/-) mice. Because lesions were significantly larger in IgM-deficient mice than in the absence of C1q, IgM protective mechanisms appear to be partially independent of classical pathway activation and apoptotic cell clearance. Levels of IgG antibodies against copper-oxidized LDL were lower in sIgM.Ldlr(-/-) mice fed a high-fat diet, suggesting compensatory consumption of IgG in the absence of IgM.
CONCLUSIONS: This study provides direct evidence that IgM antibodies play a central role in protection against atherosclerosis. The mechanism appears to be at least partly independent of classical pathway complement activation by C1q.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19620499      PMCID: PMC2761224          DOI: 10.1161/CIRCULATIONAHA.109.868158

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  44 in total

1.  Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.

Authors:  M Boes; T Schmidt; K Linkemann; B C Beaudette; A Marshak-Rothstein; J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.

Authors:  W Palinski; S Hörkkö; E Miller; U P Steinbrecher; H C Powell; L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size.

Authors:  W A Boisvert; D M Rose; A Boullier; O Quehenberger; A Sydlaske; K A Johnson; L K Curtiss; R Terkeltaub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-01-12       Impact factor: 8.311

4.  Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro.

Authors:  Pierre Quartier; Paul K Potter; Michael R Ehrenstein; Mark J Walport; Marina Botto
Journal:  Eur J Immunol       Date:  2005-01       Impact factor: 5.532

5.  Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.

Authors:  Sotirios Tsimikas; Emmanouil S Brilakis; Ryan J Lennon; Elizabeth R Miller; Joseph L Witztum; Joseph P McConnell; Kenneth S Kornman; Peter B Berger
Journal:  J Lipid Res       Date:  2006-11-08       Impact factor: 5.922

6.  Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portion.

Authors:  Zuyi Yuan; Chiharu Kishimoto; Hideto Sano; Keisuke Shioji; Yang Xu; Masayuki Yokode
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08       Impact factor: 4.733

7.  Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

Authors:  Christoph J Binder; Sohvi Hörkkö; Asheesh Dewan; Mi-Kyung Chang; Emily P Kieu; Carl S Goodyear; Peter X Shaw; Wulf Palinski; Joseph L Witztum; Gregg J Silverman
Journal:  Nat Med       Date:  2003-05-12       Impact factor: 53.440

8.  Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice.

Authors:  Alexandru Schiopu; Björn Frendéus; Bo Jansson; Ingrid Söderberg; Irena Ljungcrantz; Zufan Araya; Prediman K Shah; Roland Carlsson; Jan Nilsson; Gunilla Nordin Fredrikson
Journal:  J Am Coll Cardiol       Date:  2007-11-26       Impact factor: 24.094

9.  Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.

Authors:  W Palinski; E Miller; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

10.  Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice.

Authors:  Hafid Ait-Oufella; Kiyoka Kinugawa; Joffrey Zoll; Tabassome Simon; Jacques Boddaert; Silvia Heeneman; Olivier Blanc-Brude; Véronique Barateau; Stéphane Potteaux; Régine Merval; Bruno Esposito; Elisabeth Teissier; Mat J Daemen; Guy Lesèche; Chantal Boulanger; Alain Tedgui; Ziad Mallat
Journal:  Circulation       Date:  2007-04-09       Impact factor: 29.690

View more
  100 in total

1.  The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Talat H Malik; Andrea Cortini; Daniele Carassiti; Joseph J Boyle; Dorian O Haskard; Marina Botto
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

Review 2.  Natural IgM antibodies against oxidation-specific epitopes.

Authors:  Christoph J Binder
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

Review 3.  The importance of natural IgM: scavenger, protector and regulator.

Authors:  Michael R Ehrenstein; Clare A Notley
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

4.  Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells.

Authors:  Takayuki Kimura; Kevin Tse; Sara McArdle; Teresa Gerhardt; Jacqueline Miller; Zbigniew Mikulski; John Sidney; Alessandro Sette; Dennis Wolf; Klaus Ley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-01-13       Impact factor: 4.733

Review 5.  Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics.

Authors:  Yury I Miller; Sotirios Tsimikas
Journal:  Curr Opin Lipidol       Date:  2013-10       Impact factor: 4.776

Review 6.  Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention.

Authors:  M Wigren; J Nilsson; M J Kaplan
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

7.  Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response.

Authors:  Emilie K Grasset; Amanda Duhlin; Hanna E Agardh; Olga Ovchinnikova; Thomas Hägglöf; Mattias N Forsell; Gabrielle Paulsson-Berne; Göran K Hansson; Daniel F J Ketelhuth; Mikael C I Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

Review 8.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

9.  B cell depletion reduces the development of atherosclerosis in mice.

Authors:  Hafid Ait-Oufella; Olivier Herbin; Jean-David Bouaziz; Christoph J Binder; Catherine Uyttenhove; Ludivine Laurans; Soraya Taleb; Emily Van Vré; Bruno Esposito; José Vilar; Jérôme Sirvent; Jacques Van Snick; Alain Tedgui; Thomas F Tedder; Ziad Mallat
Journal:  J Exp Med       Date:  2010-07-05       Impact factor: 14.307

Review 10.  The expression and functions of toll-like receptors in atherosclerosis.

Authors:  Jennifer E Cole; Ektoras Georgiou; Claudia Monaco
Journal:  Mediators Inflamm       Date:  2010-06-24       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.